Login / Signup

Small-molecule Polθ inhibitors provide safe and effective tumor radiosensitization in preclinical models.

Gonzalo Rodriguez-BerrigueteMarco RanzaniRemko PrevoRathi PuliyadiNicole D MachadoHannah R BollandVal MillarDaniel V EbnerMarie BoursierAurora CeruttiAlessandro CicconiAlessandro GalbiatiDiego GrandeVera GrinkevichJayesh MajithiyaDesiree PiscitelloEeson RajendraMartin StockleySimon J BoultonEva-Leonne GöttgensRobert A HealdGraeme C M SmithHelen RobinsonGeoff S Higgins
Published in: Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
These results pave the way for future clinical trials of Polθ inhibitors in combination with radiotherapy.
Keyphrases
  • small molecule
  • clinical trial
  • early stage
  • radiation therapy
  • locally advanced
  • current status
  • protein protein
  • radiation induced
  • squamous cell carcinoma
  • cell therapy
  • rectal cancer
  • study protocol